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Chlamydia pecorum causes asymptomatic infection and pathology in ruminants, pigs, and koalas. We characterized the
antichlamydial effect of the beta lactam penicillin G on Chlamydia pecorum strain 1710S (porcine abortion isolate). Penicillin-
exposed and mock-exposed infected host cells showed equivalent inclusions numbers. Penicillin-exposed inclusions contained
aberrant bacterial forms and exhibited reduced infectivity, while mock-exposed inclusions contained normal bacterial forms and
exhibited robust infectivity. Infectious bacteria production increased upon discontinuation of penicillin exposure, compared to
continued exposure. Chlamydia-induced cell death occurred in mock-exposed controls; cell survival was improved in penicillin-
exposed infected groups. Similar results were obtained both in the presence and in the absence of the eukaryotic protein translation
inhibitor cycloheximide and at different times of initiation of penicillin exposure.These data demonstrate that penicillin G induces
the chlamydial stress response (persistence) and is not bactericidal, for this chlamydial species/strain in vitro, regardless of host cell
de novo protein synthesis.
1. Introduction
The family Chlamydiaceae comprises Gram negative, obli-
gate intracellular bacterial pathogens of humans and wild
and domestic animals. In humans, C. trachomatis causes
trachoma and blindness as well as genital tract infection
and infertility, while C. pneumoniae seropositivity is highly
prevalent and infection can be associated with respiratory
disease and atherosclerosis. C. psittaci and C. abortus are
important pathogens of birds and farm animals and are
capable of zoonotic transmission to humans. C. pecorum
is generally accepted as an important pathogen of cat-
tle, sheep, and especially koalas [1]. Symptoms associated
with C. pecorum infection include polyarthritis, pneumonia,
encephalomyelitis, and abortion in livestock and conjunctivi-
tis, urinary/reproductive disease, and infertility in koalas [1].
In pigs, C. pecorum has been associated with pneumonia,
enteritis, polyarthritis, pericarditis/pleuritis, and urogenital
infections, as well as asymptomatic infections [2].
The C. pecorum strain 1710S was originally isolated in
Austria from a swine abortion, in associationwith a large out-
break of chlamydiosis of varying clinical presentation [3, 4].
C. pecorum 1710S experimentally infected gnotobiotic piglets
demonstrated mild to moderate diarrhea and a transient
stop of weight gain; these symptoms were associated with
mild to moderate villus atrophy and mixed inflammatory
cell infiltrates in the small intestinal mucosa [5]. C. pecorum
1710S was also implicated, by sequence homology of cloned
Chlamydia omp1 genus-specific PCR products, in 8 of 9
Chlamydia-positive aborted fetuses of Swiss swine [6, 7],
emphasizing the pathogenic potential of this isolate. More
recently, 51 female calves in the US, evaluated from birth to
6 months, all became C. pecorum-positive by 23S rRNA PCR
and ompA genotyping of conjunctival and vaginal swabs; C.
pecorum 1710S was 1 of the 3 C. pecorum strains identified
by PCR product sequencing [8]. Interestingly, in this study,
C. pecorum infections were associated with failure to gain
weight and increased conjunctival redness but not intestinal
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symptoms or other diseases [8]. Taken together, these data
indicate that C. pecorum 1710S has pathogenic potential
and/or can lead to decrease of animal weight gain in both
swine and cattle.
In livestock, infections are routinely treated with antibi-
otics, especially tetracyclines [9]. However, the use of tetra-
cyclines has been shown to be both ineffective in eradicating
chlamydial infections in swine [10] and associated with the
presence of tetracycline-resistant C. suis [11]. Beta lactam
antibiotics, such as penicillin and amoxicillin, are widely used
for various infections, and their persistence in animal tissue
is a particular concern in meat and dairy animals, largely due
to possible dangerous effects in penicillin-allergic individuals
[12, 13]. In swine specifically, penicillin G has been detected
in various tissues/organs, especially the kidney, for up to 39
days after injection and is expected to persist in detectable
amounts for up to 47 days [14, 15]. C. pecorum infections in
pigs are frequently asymptomatic and/or are not diagnosed
because they are considered unimportant pathogens in swine
[2]. At the same time, the use of both veterinary-approved
and off-label antibiotics is widespread in pig production.
Therefore, it is likely that pigs asymptomatically infected with
C. pecorum are treatedwith antibiotics administered for other
purposes.
In the more well-studied Chlamydiae, such as C. tra-
chomatis, C. muridarum, C. pneumoniae and C. psittaci, beta
lactam antibiotics, such as penicillin and ampicillin, have his-
torically and consistently been demonstrated to be ineffective
against eradicating chlamydial infection, both in vitro and in
animal models [16–22]. Instead of killing the Chlamydiae,
beta lactams induce persistence or the chlamydial stress
response, defined as a viable but noninfectious divergence
from the normal chlamydial biphasic developmental cycle
[23]. Persistent/stressed Chlamydiae are less susceptible to
killing by antibiotics such as azithromycin [21, 24], unde-
tectable by culture, and capable of resuming infectious
bacteria production upon removal of the stressor/antibiotic
[25].
Information about the efficacy of antibiotics against C.
pecorum specifically, however, is very limited. A single in vitro
study of 3 calf and lamb C. pecorum isolates indicated that
macrolides, tetracyclines, and quinolones, but not the beta
lactam ampicillin, prevented inclusion formation; however,
AB induction, infectious bacterial production and potential
recovery upon removal of ampicillin were not evaluated [26].
More recently, 10 koala C. pecorum isolates were evaluated
for susceptibility to enrofloxacin, chloramphenicol, and flor-
fenicol, but beta lactam antibiotics were not considered [27].
Thus, the ability of beta lactam antibiotics to reversibly abro-
gateC. pecorum infectivity, by definition inducing chlamydial
stress/persistence, has not been demonstrated.The aim of our
study is characterization of the in vitro antichlamydial effect
of the beta lactam penicillin G on the C. pecorum porcine
abortion strain 1710S, a potentially significant pathogen of
swine and other economically important animals.
Our data indicate that the effect of penicillin G on C.
pecorum 1710S is consistent with the definition of chlamydial
stress/persistence. Specifically, persistence/chlamydial stress
is characterized by reversible reduced or abolished infectious
bacteria production and aberrant, enlarged bacterial forms
called aberrant bodies (AB) detectable by immunofluores-
cence and transmission electron microscopy [25, 28–30]. We
further determine that, under the experimental conditions
used herein, penicillin G induces chlamydial stress in C.
pecorum 1710S regardless of inclusion/exclusion of cyclohex-
imide (which limits host de novo protein synthesis), though
recovery is more robust in the presence of cycloheximide.
Finally, initiation of penicillin exposure at 0 or 14 hours
postinfection (hpi) yields equivalent reductions of infectious
EB production and subsequent recovery of infectious EB
production.
2. Materials and Methods
2.1. Host Cells. HeLa cells (human cervical adenocar-
cinoma epithelial cells, CCL-2, American Type Culture
Collection, Manassas, VA, USA) were cultured for cell
propagation and maintenance at 37∘C and 5% CO
2
in
growth medium. Growth medium was comprised of Min-
imal Essential Medium (MEM) with Earle’s salts, 25mM
HEPES, without L-Glutamine (GIBCO, Invitrogen, Carlsbad,
CA, USA) supplemented with 10% fetal calf serum (FCS,
BioConcept, Allschwil, Switzerland), 4mM GlutaMAX-I
(200mM, GIBCO), 1% MEM Nonessential Amino Acids
(100x, GIBCO), and 0.2mg/mL gentamycin (50mg/mL,
GIBCO). For experiments, cells were seeded in 24-well
plates (Techno Plastic Products AG (TPP), Trasadingen,
Switzerland) at 3 × 105 cells per well in 1mL growth medium
without gentamycin. Cells were seeded on 13mm diameter
glass coverslips (Sterilin Limited, Thermo Fisher Scientific,
Cambridge, UK) for immunofluorescence (IF)microscopy or
transmission electron microscopy (TEM) or directly in the
24-well plates, without coverslips, for titration by subpassage.
Infectionmedium, used for inoculating cells withChlamydia,
consisted of all growth medium components except FCS and
gentamycin. Incubation medium, used to replace infection
medium after inoculation with Chlamydia, consisted of all
growth medium components except gentamycin and was
further supplemented with 1𝜇g/mL cycloheximide (Sigma-
Aldrich, St. Louis, MO, USA) immediately before use. In
some experiments, growth medium without cycloheximide
supplementation was used for incubation.
2.2. Chlamydial Strain. C. pecorum 1710S (isolate from a
swine abortion) was kindly provided by Professor Storz,
Baton Rouge, LA, USA [3] and propagated in HeLa cells.
Crude C. pecorum stock was generated by mechanical dis-
ruption (scraping) of infected HeLa cells into infection
medium, sonication (Branson Sonifier 250; Branson Ultra-
sonics, Danbury, CT, USA) on ice, centrifugation of infec-
tious particles from the medium at 10,000 g at 4∘C for 45
minutes, and suspension in SPG medium. Stock was stored
at −80∘C and frozen stock aliquots were thawed immediately
before infections were carried out. SPG medium consisted of
218mM sucrose (Sigma-Aldrich), 3.76mMKH
2
PO
4
(Sigma-
Aldrich), 7.1mM K
2
HPO
4
(Merck Eurolab AG, Dietlikon,
Switzerland), and 5mM GlutaMAX-100 (GIBCO).
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Figure 1: Study Design.The diagram illustrates infection and expo-
sure beginning at 𝑇
0
, immediately postinfection, or at 𝑇
14
, 14 hours
postinfection (hpi). HeLa cells were infected with Chlamydia peco-
rum 1710S, exposed to penicillin G (PenG) in incubation medium,
and incubated until 35 hpi, at which time samples were collected
for analysis. For recovery experiments, incubation medium was
changed for continued PenG exposure or discontinued exposure
(recovery), and samples were subjected to 24 or 48 hours (h) of
additional incubation before sample collection.
2.3. Penicillin Reagent. Penicillin G sodium salt (Sigma-
Aldrich) was dissolved in sterile deionized water to a stock
concentration of 20,000 units (U)/mL, filter-sterilized, and
stored at −20∘C. Aliquots of this penicillin G stock were
thawed and further diluted in sterile water to a working
concentration of 100U/mL immediately before use. Working
solutions were stored for less than one week at 4∘C, as
per manufacturer’s recommendation. The final penicillin G
concentration used in experiments, 1 U/mL, was achieved
by 10 𝜇L/mL dilution of working solution in the incubation
medium of penicillin-exposed samples. Sterile water (dilu-
ent) of an equivalent volume was similarly used to generate
control (mock-exposed) samples.
2.4. Study Design, Infection, and Exposure of Infected Host
Cells to Penicillin. HeLa cells were cultivated overnight in 24-
well plates and were subsequently infected with C. pecorum
1710S at 1 multiplicity of infection (MOI) in 1mL infection
medium per well and centrifuged for 1 hour (h) at 1000 g
and 25∘C. After centrifugation, infectionmediumwas imme-
diately replaced with incubation medium and cultures were
incubated at 37∘C and 5% CO
2
as previously described [31].
The crude stocks used resulted in approximate control infec-
tion rates of 50%; this corresponded to approximately 107
recoverable inclusion-forming units (IFU) per well formock-
exposed infected cells after 35 hours of incubation.The effect
of penicillin G on C. pecorum inclusions was determined by
adding penicillin G to a final concentration of 1 U/mL, to
the incubation medium of infected cells at 𝑇
0
, immediately
after infection, or at 𝑇
14
, 14 hours after infection (Figure 1).
In experiments evaluating recovery from penicillin G, incu-
bation medium was changed at 35 hours postinfection (hpi)
to continue exposure or discontinue exposure (recovery) to
penicillin. This time, 35 hpi, corresponds to the presence of
mature C. pecorum 1710S inclusions in HeLa culture, but no
significant host cell lysis, as previously reported [32].
At the indicated times, samples were collected and pro-
cessed for further analysis as previously described [31]. For
immunofluorescence (IF) microscopy, cells were fixed with
absolute methanol (−20∘C) for 10 minutes. For transmission
electron microscopy (TEM), cells were fixed with 2.5% glu-
taraldehyde (Electron Microscopy Sciences, Fort Washing-
ton,USA) for 1 h and embedded in epoxy resin (Fluka; Sigma-
Aldrich) by routine methods. For titration by subpassage
infected monolayers collected at 35 hpi were scraped into
1mL of fresh infection medium and stored at −80∘C. Because
C. pecorum 1710S-infectedHeLa cells undergo significant lysis
and EB release soon after 35 hpi, as previously reported [32],
for continued exposure or recovery sample collection for
titration by subpassage, infected monolayers were scraped
into the existing incubation medium and stored at −80∘C. In
all experiments, biological duplicates were generated for each
experimental condition.
2.5. IF Microscopy. C. pecorum inclusions were visual-
ized using 1 : 200 diluted Chlamydiaceae family-specific
mouse monoclonal antibody directed against the chlamydial
lipopolysaccharide (LPS, Clone ACI-P; Progen, Heidelberg,
Germany) and 1 : 500 diluted Alexa Fluor 488-conjugated
secondary goat anti-mouse antibody (Molecular Probes,
Eugene, OR, USA). Host and chlamydial DNA were labeled
with 1 𝜇g/mL 4󸀠,6-diamidino-2󸀠-phenylindole dihydrochlo-
ride (DAPI, Molecular Probes). Coverslips were mounted
with FluoreGuard mounting medium (Hard Set; ScyTek
Laboratories Inc., Logan, UT, USA) on glass slides. Slides
were evaluated using a Leica DMLB fluorescence micro-
scope (Leica Microsystems, Wetzlar, Germany) under oil
immersion at 1000x magnification with a 1006 objective (PL
FLUOTAR 100x/1.30, OIL, ∞/0.17/D, Leica Microsystems)
and a 106 ocular objective (Leica L-Plan 10x/25M, Leica
Microsystems). To determine percent of cells infected (inclu-
sions per nucleus) and mean number of nuclei per field
(to evaluate possible cell loss from the monolayer), HeLa
nuclei and corresponding chlamydial inclusions in each of
10 randomly selected microscopic fields were counted per
duplicate coverslip (at least 200 HeLa nuclei per coverslip),
and the mean of coverslips values was generated for each
experimental condition. Representative microscopic images
were captured using BonTec software (BonTec) and a UI-
2250SE-C-HQ camera (uEye, IDS Imaging Development
Systems GmbH, Obersulm, Germany).
2.6. Chlamydial Titration by Subpassage. HeLa cells were
grown on glass coverslips as described above. Immediately
prior to use, the previously prepared and frozen samples
were thawed and sonicated on ice for 5 minutes. Sonicated
samples were serially diluted in infection medium on the
prepared HeLa cells. Centrifugation, infection medium
replacement with incubation medium (containing 1 𝜇g/mL
cycloheximide for all experiments), and incubation were
carried out as described for infection of host cells. Fixation
and immunostaining were performed exactly as described
for IF microscopy. The number of inclusions in 30 random
microscopic fields per duplicate coverslip was counted using
a Leica fluorescence microscope at 200x magnification with
a 206 objective (PL FLUOTAR 20x/0.50 PH 2, ∞/0.17/B)
and a 106 ocular objective (Leica L-Plan 10x/25M, Leica
Microsystems), and the mean of coverslips values was
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Figure 2: Penicillin G exposure induces aberrant body formation and reduces infectious elementary body production inChlamydia pecorum.
C. pecorum-infected HeLa cells were exposed to penicillin G (PenG), at 0 hours postinfection (hpi) until 35 hpi. Control infected cells were
exposed to diluent only (mock). Cycloheximide was included (a) or not included (b) in the incubation medium. Inclusions were visualized
using an antibody directed against chlamydial lipopolysaccharide (green), and DNA was labeled with 4󸀠,6-diamidino-2󸀠-phenylindole
dihydrochloride (blue). Percent of host cells infected and mean nuclei per field was determined by evaluation of 10 fields (≥200 cells), per
coverslip, per sample. Representative immunofluorescence and transmission electron microscopic images illustrate normal inclusions in
mock-exposed controls and inclusions containing aberrant bodies upon penicillin exposure. Infectious elementary body production was
determined by titration by subpassage and expressed as inclusion-forming units (IFU)/mL. Results are means ± standard deviation. The
two-tailed t-test was used to compare means; p ≤ 0.05 = significant (∗); 𝑛 = 3 (a) or 𝑛 = 2 (b). Scale bars = 5 𝜇m.
generated for each experimental condition. IFU/mL of
undiluted inoculum (representing IFU per total collected
material from a single well of a 24-well plate) was calculated
according to previously published methods [33].
2.7. TEM. Ultrathin (80 nm) sections were mounted on gold
grids (Merck) and contrasted with uranyl acetate dehydrate
(Fluka; Sigma-Aldrich) and lead citrate (Merck). Sections
were subsequently evaluated using a Philips CM10 electron
microscope (Software release version 5.1; FEI Company,
Hillsboro,OR,USA) and imaged using aGatanOrius SC 1000
CCD Camera with software version Digital Micrograph 2.30
(Gatan Inc.,Warrendale, PA, USA). All images were analyzed
using PhotoshopCS6 software (Adobe Systems Incorporated,
San Jose, CA, USA). To determine the presence of AB,
bacterial morphology analysis was carried out, as previously
described [34]: EB (dark, 0.25–0.5 𝜇m), IB (intermediate
bodies; dark center and pale periphery, equivalent in size to
EB or RB), RB (pale, 0.5–1 𝜇m), and AB (pale, ≥2𝜇m).
2.8. Statistical Analysis. In all experiments, biological dupli-
cates were averaged to generate results. Statistical analyses
were performed using Microsoft Excel. Significance of the
difference of means was determined by unpaired 𝑡-test and
𝑝 values of <0.05 were considered significant. 𝑝 values
were confirmed using the GraphPad QuickCalcs Web site:
http://www.graphpad.com/quickcalcs/ttest1/ (accessed June
2014). Unless stated otherwise, results are displayed as means
± standard deviation, of the results from 2 or 3 independent
experiments. In cases where a single confirmatory experi-
ment is noted, results are displayed as means ± standard
deviation, of the two biological duplicates.
3. Results and Discussion
In this study we evaluated the effect of the beta lactam antibi-
otic penicillin G on a porcine abortion strain of Chlamydia
pecorum (1710S). Based on previous reports that various
chlamydial species enter chlamydial stress/persistence upon
beta lactam exposure [16–22], we hypothesized that penicillin
G would induce chlamydial stress in C. pecorum 1710S.
Because inclusion/exclusion of the eukaryotic protein synthe-
sis inhibitor cycloheximide has the potential to influence the
effect of beta lactams on Chlamydiae [35], we evaluated the
effect of penicillin G on C. pecorum in the presence of cyclo-
heximide and performed a single confirmatory experiment in
the absence of cycloheximide.
HeLa cells were infected with C. pecorum, exposed to
penicillin G or sterile water (mock-exposed control) in the
cycloheximide-containing or cycloheximide-free incubation
medium at 0 hours postinfection (hpi), and incubated until
35 hpi (Figure 1). For cycloheximide-exposed HeLa/C. peco-
rum (Figure 2(a)), infection rates of 50–52% of diluent- or
International Journal of Microbiology 5
Table 1: Chlamydia pecorum recovers infectious elementary body production (inclusion-forming units/mL) upon discontinuation of
penicillin G exposure.
Hours Experimental group Experiment 1 𝑝 Experiment 2 𝑝
24
Mock 1.21 × 108 ± 2.20 × 106 5.11 × 107 ± 1.21 × 106
PenG 0 hpi 3.25 × 101 ± 1.77 × 101 0.0003# 1.00 × 101 ± 7.07 × 100 0.0002#
PenG 0 hpi recovery 1.77 × 105 ± 1.00 × 104 0.0016## 6.36 × 103 ± 2.75 × 103 0.0825##
PenG 14 hpi 1.75 × 101 ± 3.54 × 100 0.0003# 3.00 × 101 ± 1.41 × 101 0.0002#
PenG 14 hpi recovery 1.63 × 105 ± 1.40 × 104 0.0037## 1.52 × 104 ± 2.13 × 104 0.4196##
48
Mock 4.89 × 107 ± 2.73 × 107 2.73 × 107 ± 9.06 × 105
PenG 0 hpi 5.50 × 101 ± 2.83 × 101 0.0026# 3.00 × 101 ± 7.07 × 100 0.0019#
PenG 0 hpi recovery 1.66 × 106 ± 1.18 × 105 0.1345## 1.02 × 107 ± 5.62 × 105 0.0015##
PenG 14 hpi 1.28 × 102 ± 3.54 × 100 0.1314# 6.75 × 101 ± 3.54 × 100 0.0249#
PenG 14 hpi recovery 9.69 × 105 ± 6.02 × 103 <0.0001## 6.11 × 106 ± 4.73 × 106 0.2091##
C. pecorum 1710S-infected HeLa cells were exposed to diluent only (mock) or to penicillin G at 0 hours postinfection (hpi) or 14 hpi. At 35 hpi, medium was
changed and exposurewas continued or discontinued (recovery) for 24 or 48 hours. Inclusion counts generated frombiological duplicates were used to calculate
mean inclusion-forming units/mL. Results from 2 independent experiments evaluating 24 h of recovery or 48 h of recovery are shown. 𝑝 values for groups
compared to corresponding mock (#) or corresponding continued exposure groups (##) are shown; 𝑝 ≤ 0.05 = significant.
0 hpi penicillin-exposed cells were observed.Mean nuclei per
field values were 22 and 25 for diluent- and 0 hpi penicillin-
exposed infected cells, respectively. When cycloheximide
was omitted (Figure 2(b)), an infection rate of 23% was
observed for mock- and 0 hpi penicillin-exposed cells. In
the absence of cycloheximide, mean nuclei per field values
were 35 for mock-exposed cells and 36 for 0 hpi penicillin-
exposed cells. Thus, penicillin G had no effect on host cell
infection rate or host cell loss from the monolayer at 35 hpi,
regardless of time of initiation of penicillin exposure, whether
or not cycloheximide was included. However, as expected,
the omission of cycloheximide allowed host cell division to
continue and resulted in increased nuclei per field compared
to cycloheximide-containing cultures. Additionally, infection
rates in the presence of cycloheximide were approximately
twice those observed in the absence of cycloheximide.
By IF microscopy, AB were easily observed in all
inclusions in 0 hpi penicillin-exposed infected cells, whether
cycloheximide was included (Figure 2(a)) or excluded
(Figure 2(b)). Corresponding mock-exposed infected cells
contained no AB, regardless of the inclusion/exclusion of
cycloheximide. Confirmatory TEM analysis (Figure 2(a))
demonstrated that the AB observed by IF microscopy were
at least 2 𝜇m in diameter, as is typical for AB, and that
mock-exposed controls included EB and RB of normal size
and morphology [34]. Titration by subpassage was used to
evaluate infectious EB production, measured as inclusion-
forming units (IFU) per mL. Mock-exposed inclusions
cultured in the presence of cycloheximide yielded 7.39 ×
10
7 IFU/mL (per well of cells), while 0 hpi penicillin-exposed
inclusions yielded 5.43 × 103 IFU/mL (Figure 2(a)). In the
absence of cycloheximide, mock-exposed inclusions yielded
4.42 × 106 IFU/mL, while 0 hpi penicillin-exposed inclusions
yielded 1.25 × 101 IFU/mL (Figure 2(b)). Inclusion of cyclo-
heximide resulted in increased IFU/mL in mock-exposed
controls compared to exclusion of cycloheximide, as expected
given the increased infection rate of host cells also observed.
However, the observed penicillin-dependent decreases in
IFU/mL constituted a similar reduction to <1% of the mock-
exposed control whether or not cycloheximide was included.
To determine the ability of C. pecorum to recover from
penicillin exposure, infected cells were exposed at 0 hpi
until 35 hpi, when the medium was changed and exposure
was continued or discontinued (recovery) for 24 h or 48 h
(Figure 1). Cycloheximide exposure was concomitantly con-
tinued (Figure 3(a)) or excluded (Figures 3(b) and 3(c)) for
the duration of incubation. Upon 24 h or 48 h of continued
culture, significantChlamydia-induced cell death occurred in
mock-exposed controls, while cell survival was comparatively
improved in 0 hpi penicillin-exposed groups, regardless of
inclusion/exclusion of cycloheximide. In the presence of
cycloheximide, mean nuclei per field values ranged from
17 to 20 for 0 hpi penicillin-exposed cells, upon both 24 h
and 48 h of continued culture, while mock-exposed controls
retained only 1–3 nuclei per field (Figure 3(a)). In the absence
of cycloheximide, mean nuclei per field values were larger
and ranged from 47 to 52 for 0 hpi penicillin-exposed cells
at 24 and 48 h of further culture, while mock-exposed cells
retained 12–25 nuclei per field (Figure 3(b)). Therefore, for
24 h and 48 h continued culture, penicillin G exposure signif-
icantly protected HeLa cells from C. pecorum 1710S-induced
cell death independent of cycloheximide inclusion/exclusion.
Thus, cells remained present in both cycloheximide-exposed
and unexposed HeLa monolayers as a source of con-
stituents/metabolites for potentially recovering Chlamydiae.
Infectious EB production (IFU/mL) increased upon dis-
continuation of 0 hpi-initiated penicillin exposure, compared
to continued penicillin exposure, for both cycloheximide-
exposed infected cells (Table 1) and unexposed HeLa/C.
pecorum (Figure 3(c)). Although the statistical significance
of these changes was inconsistent due to high variability, the
observed changes were generally substantial. Approximately
600- to 5000-fold increases for 0 hpi penicillin exposure were
observed when comparing discontinued exposure (recovery)
compared to continued penicillin exposure, in the presence
of cycloheximide, at 24 h of continued culture (Table 1).
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Figure 3: Penicillin G exposure prevents Chlamydia pecorum-mediated cell death and C. pecorum recovers infectivity upon discontinuation
of penicillin exposure. C. pecorum-infected HeLa cells were penicillin G (PenG) exposed or diluent exposed (mock) from 0 to 35 hours
postinfection (hpi). Cycloheximide was included (a) or not included (b, c) in the incubation medium. At 35 hpi, medium was changed to
continue or discontinue (recovery, REC) penicillin exposure for 24 or 48 hours (h) and cycloheximide was maintained for (a). Inclusions
were visualized and mean nuclei per field were determined as described for Figure 2. Representative immunofluorescence microscopic
images illustrate cell death inmock-exposed controls, inclusions containing aberrant bodies upon continued penicillin exposure and normal-
appearing inclusions upon recovery (REC). Production of infectious elementary bodies was determined by titration by subpassage and
expressed as inclusion-forming units (IFU)/mL. Results are means ± standard deviation. The two-tailed t-test was used to compare means; p
≤ 0.05 = significant (∗); 𝑛 = 2. Scale bars = 5 𝜇m.
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Similarly, but to a greater extent, approximately 30,000- to
340,000-fold increases in IFU/mL of 0 hpi penicillin-exposed
groups were observed in cycloheximide-including recovery
conditions, compared to continued exposure upon 48 h of
continued culture (Table 1). In the absence of cycloheximide,
results were similar but more moderate in nature. At 24 h
of continued culture, discontinuation of penicillin exposure
resulted in a 12-fold increase in IFU/mL compared to contin-
ued exposure, while, at 48 h of continued culture, an 82-fold
increase in IFU/mL was observed in discontinued penicillin
exposure versus continued exposure (Figure 3(c)). Thus, the
inclusion of cycloheximide potentiated a more robust recov-
ery from penicillin G exposure. However, either inclusion or
exclusion of cycloheximide allowed increased infectious C.
pecorum EB production upon discontinuation of penicillin
exposure. Furthermore, regardless of the inclusion/exclusion
of cycloheximide, increased recovery time from 24 h to 48 h
of continued culture was associated with increased infectious
EB production.
AB were consistently observed by IF microscopy upon
continued penicillin exposure, regardless of the dura-
tion of exposure or the presence (Figure 3(a)) or absence
(Figure 3(b)) of cycloheximide in the assay. Some, but not
all, recovery group inclusions showed areas of denser, more
granular LPS-positive staining, consistent with the appear-
ance of mock-exposed inclusions at 35 hpi (Figures 3(a) and
3(b) right panels, compared to Figures 2(a) and 2(b) left
panels). These inclusions were frequently associated with
shrunken, brightly staining host cell nuclei, indicating that as
inclusions became more normal in appearance, C. pecorum
1710S was still capable of exerting its cytotoxic effect on HeLa
cells. Mock-exposed cells showed no AB, at 24 h or 48 h of
continued culture, regardless of inclusion/exclusion of cyclo-
heximide or duration of incubation (Figures 3(a) and 3(b)).
Initiation of penicillin G exposure at 14 hpi (see Figure 1),
in the presence of cycloheximide, was carried out to
determine if Chlamydiae being at the stage of early RB
development upon exposure might modulate the described
effects of penicillin G exposure or subsequent continua-
tion/discontinuation of this exposure onChlamydiae. During
0 hpi penicillin G exposure, EB are exposed to penicillin as
they enter the host cells and initiate inclusion formation.
However, 14 hpi addition of penicillin postpones the exposure
of the Chlamydiae until EB have differentiated into RB, and
early RB replication/development is starting or will soon
start, but redifferentiation into EB has not begun [36]. Thus,
upon 𝑇
14
exposure, intracellular RB are the bacterial forms
initially exposed to penicillin.
We found, by IF microscopy and TEM (not shown),
that 14 hpi penicillin G-exposed HeLa/C. pecorum had nor-
mal inclusions in mock-exposed groups and AB-containing
inclusions in 14 hpi penicillin-exposed groups at 35 hpi and
at 24 h or 48 h of continued exposure, similar to the 0 hpi
penicillin exposure results. Later initiation of exposure was
associated with somewhat larger numbers (usually 6 to 8
AB, versus 1-2 AB per inclusion) of slightly smaller AB
(though still at least 2 𝜇m in diameter). Upon 14 hpi penicillin
exposure, the mean nuclei per field value was 24 and the host
cell infection rate was 51% at 35 hpi. For 14 hpi initiation of
penicillin exposure and subsequent continuation or discon-
tinuation of penicillin exposure, mean nuclei per field values
at 24 h and 48 h of continued culture ranged from 16 to 22
and 15 to 16, respectively. These 35 hpi and 24/48 h data are
statistically equivalent to those observed for 0 hpi penicillin
exposure. Additionally, upon 14 hpi initiation of penicillin
exposure, the IFU/mLvalue at 35 hpi (2.08× 104 IFU/mL)was
less than 1% of themock-exposed control value, similar to the
0 hpi results. Furthermore, IFU/mL values of discontinued
penicillin exposure versus continued penicillin exposure (see
Table 1) were very similar regardless of time of initiation of
penicillin exposure. Later initiation of exposure, and thus
decreased total penicillin exposure time, was not correlated
with increased infectious EB production (IFU/mL).
Beta lactams have long been considered nonbacterici-
dal against the Chlamydiae, instead inducing, in vitro, a
reversible state of bacterial stress, termed persistence or
chlamydial stress. The original report of in vitro chlamy-
dial persistence [16] described aberrant bacterial forms and
reduced infectivity upon penicillin G exposure and demon-
strated the reversibility that defines chlamydial persistence,
a phenomenon now known to be inducible by various stres-
sors including nutrient deprivation, host interferon gamma
production, and coinfection [30]. The in vitro antichlamydial
effect of beta lactams has also been reported as bactericidal
under some conditions, namely, exposure to penicillin early
after chlamydial infection and specifically in the absence of
pharmacologically (cycloheximide) inhibited host de novo
protein synthesis [35]. Chlamydiae were thought to lack
peptidoglycan, the target of beta lactams, so the response
of Chlamydiae to beta lactams has been anomalous [37]. A
recent report providing evidence of chlamydial peptidogly-
can [38] clarifies the antichlamydial effect of beta lactams and
emphasizes the role they may play in modulation of natural
infections.
In this study, experiments were primarily designed to
facilitate C. pecorum recovery from penicillin to determine if
this species can, under conditions permissive for persistence
induction, exhibit the hallmarks of persistence. In a previous
report, exclusion of cycloheximide was sufficient to render
C. trachomatis incapable of recovery from 1, 10, or 100U/mL
penicillin G exposure, while recovery from 100U/mL peni-
cillin G was possible in the presence of cycloheximide [35].
Thus, we included cycloheximide in our experiments but
also compared the effects to those elicited in the absence
of cycloheximide. We found that although cycloheximide
potentiated the recovery of C. pecorum 1710S infectious EB
production upon the removal of penicillin G, it was not
required for such recovery. In vivo, local modulation of host
protein synthesis may occur via mechanisms in response
to chlamydial infection and/or infection with other bacteria
or viruses. These may include immune-mediated interferon-
dependent tryptophan reduction [29] or specific antiviral
responses [39], for example.Therefore, though cycloheximide
may be considered to limit the biological relevance of in
vitro models of chlamydial infection, reduced host protein
translation may impact chlamydial entry into and exit from
the chlamydial stress response in vivo.
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HeLa cells, being human-derived cells, do not represent
a natural host species for C. pecorum. However, previous
reports indicate that penicillin G exposure of C. trachomatis-
infected HeLa cells, both in the presence [35] and the absence
[22] of cycloheximide, induces an antichlamydial effect con-
sistent with persistence. Additionally, recent work in our
laboratory [32] showed that damage associated molecular
patterns (DAMP) exposure of C. pecorum-infected cells also
elicits an antichlamydial effect in HeLa cells that is consistent
with persistence.
The concentration of penicillin G used in this study was
chosen based on preliminary optimization (not shown) of the
induction of AB formation in various chlamydial species and
host cells lines, in which 1–100U/mL consistently yielded AB
in all inclusions. While studies evaluating penicillin-induced
persistence frequently use hundreds ofU/mL, a recent in vitro
study showed penicillin G reduced C. trachomatis infectious
EB production by >99% at 0.02U/mL [22]. Thus, we chose
a concentration not in substantial excess of that required to
induce C. pecorum 1710S AB formation and to reduce infec-
tious EB production. 1 U/mL penicillin G induced AB forma-
tion in all inclusions and reduced infectious EB production
to <1% of control values. Earlier exposure did not result in
statistically reduced infectious EB production. Furthermore,
later exposure, resulting in more AB per inclusion but a
similar number of inclusions compared to early exposure or
mock exposure, did not increase recovery of infectious EB
production upon cessation of penicillin exposure.
Chlamydial species is also likely to impact the effect of
beta lactams both in vitro and in vivo. We recently demon-
strated that C. pecorum is more capable of recovering from
DAMP-induced reduced infectious EB production than C.
trachomatis [32]; this suggests that C. pecorum may be more
able to recover from persistence induced by various stressors
than C. trachomatis. Human strains of C. pneumoniae are
more able to recover from penicillin-induced persistence
than animal strains [40], suggesting that species- and strain-
specific sensitivity to stressors, including antibiotics, may be
common within the Chlamydiae. Experimental parameters
such as specific beta lactam drug used, timing of initiation
exposure and duration of exposure, and timing of removal
of drug for recovery and duration of recovery, as well
as differences in measurement/determination of infectivity
could be expected to impact degree and detection of entry
into and recovery from beta lactam-induced chlamydial
stress/persistence. Such factors, as well as biological variation
amongst the Chlamydiae, are also likely to contribute to
differing reports of bactericidal and bacteriostatic effects of
beta lactam antibiotics amongst the Chlamydiae.
Questions remain concerning the biological importance
of chlamydial persistence/stress in vivo, especially in naturally
occurring infections. While aberrant chlamydial forms have
been demonstrated in porcine [41] and human [42] spec-
imens, veterinary/medical consequences are debated [23].
Results from a recent mouse model study demonstrated
that beta lactam-induced persistent chlamydial genital infec-
tion is more prone to azithromycin treatment failure than
productive chlamydial infection [21]. Intestinal chlamydial
infection in mice has also been demonstrated to be more
resistant to azithromycin than genital infection [43]. Asymp-
tomatic gastrointestinal C. pecorum infections and other
such chlamydial infections are common and are subject to
beta lactam exposure due to widespread agricultural use of
these drugs. Thus, beta lactam therapy is likely to expose
undetected Chlamydiae to persistence inducers. While it is
known that persistent/stressed Chlamydiae exhibit altered
protein expression in vitro compared to nonstressed controls
[44–48], the potential effect of AB/chlamydial stress on
porcine abortion rates, failure to gain weight, or other clinical
symptoms is entirely unknown but interesting and potentially
important.
Recent clinical findings suggest that asymptomatic
human gastrointestinal chlamydial infection also occurs [49–
51]. These data and clinical findings suggest that difficulties
in elimination of chlamydial infection may be common to
both humans and other animals and may be modulated by
beta lactam exposure. In a recent porcine-specific example
of failure to eliminate chlamydial infection with standard
antimicrobial therapy, asymptomatic chlamydial intestinal
infection in multiple pig herds in Switzerland remained
present independent of antibiotic treatments, including
tetracycline treatment [10].
4. Conclusions
We report that, as hypothesized, C. pecorum 1710S enters a
state of chlamydial/stress persistence upon beta lactam expo-
sure. However, the extensive biological and genetic diversity
of C. pecorum, including various clinical presentations and
serological characteristics, in vitro growth characteristics, and
genetic characteristics such as the recently demonstrated
differential presence of a novel plasmid [4, 52–54], suggests
that the wide range of strains comprising this species war-
rant continued scrutiny. Since the effect of asymptomatic
chlamydial infections on long-term fitness of animals and
humans and the role of chlamydial stress/persistence under
such circumstances is unknown, the effects of beta lactams
on the Chlamydiae are of continued veterinary and medical
interest.
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